PharmaResearch

Established in 1993, PharmaResearch has diversified its business by providing pharmaceutical license consulting and engaging in the import and sales of innovative pharmaceuticals. Through significant milestones, company has solidified its position as a comprehensive pharmaceutical manufacturer, such as completion of the pharmaceutical manufacturing technology of regenerative substance PDRN derived from marine resources as the first in Korea in 2009; GMP pharmaceutical factory certification in 2013; public listing on the KOSDAQ in July 2015; and being selected as an innovative pharmaceutical company in 2016.

In addition, PharmaResearch is enhancing its portfolio with DOT™ (DNA Optimizing Technology) PDRN (Polydeoxyribonucleotide) and DOT™ PN (Polynucleotide)-based pharmaceuticals, aesthetic medical devices, and derma cosmetics. PharmaResearch is building a pipeline for ’Total Aesthetic Solution,’ including a lineup of botulinum toxin preparations through business expansion for its second leap in the anti-aging market.